• Je něco špatně v tomto záznamu ?

N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation

P. Chytil, T. Etrych, J. Kříž, V. Subr, K. Ulbrich,

. 2010 ; 41 (3-4) : 473-482. [pub] 20100807

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026864

Controlled radical reversible addition-fragmentation chain transfer (RAFT) polymerisation was used to prepare water-soluble polymer-drug carriers based on copolymers of N-(2-hydroxypropyl)methacrylamide (HPMA) with a hydrazide group-containing monomer, showing well-defined structure with narrow molecular weight distribution (approx. 1.1-1.2). The anticancer therapeutic doxorubicin was bound to the polymeric carrier by a hydrazone bond, enabling pH-controlled release under mildly acid conditions that mimics the environment in endosomes/lysosomes of tumour cells. RAFT polymerisation facilitated the synthesis of semitelechelic copolymers, which were used in the synthesis of monoclonal anti-CD20 antibody-polymer-drug conjugate designed for cell-specific tumour targeting. They were also used for producing a biodegradable high-molecular-weight graft polymer-drug conjugate that degrade in the presence of glutathione, which is designed for passive targeting to solid tumours. The conjugates exhibited well-defined structures with narrow molecular weight distributions of approx. 1.3 and pH-controlled drug release.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026864
003      
CZ-PrNML
005      
20160318074809.0
007      
ta
008      
120816s2010 ne f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.ejps.2010.08.003 $2 doi
035    __
$a (PubMed)20696244
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Chytil, Petr $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, 162 06 Prague 6, Czech Republic. chytil@imc.cas.cz $7 _AN032430
245    10
$a N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation / $c P. Chytil, T. Etrych, J. Kříž, V. Subr, K. Ulbrich,
520    9_
$a Controlled radical reversible addition-fragmentation chain transfer (RAFT) polymerisation was used to prepare water-soluble polymer-drug carriers based on copolymers of N-(2-hydroxypropyl)methacrylamide (HPMA) with a hydrazide group-containing monomer, showing well-defined structure with narrow molecular weight distribution (approx. 1.1-1.2). The anticancer therapeutic doxorubicin was bound to the polymeric carrier by a hydrazone bond, enabling pH-controlled release under mildly acid conditions that mimics the environment in endosomes/lysosomes of tumour cells. RAFT polymerisation facilitated the synthesis of semitelechelic copolymers, which were used in the synthesis of monoclonal anti-CD20 antibody-polymer-drug conjugate designed for cell-specific tumour targeting. They were also used for producing a biodegradable high-molecular-weight graft polymer-drug conjugate that degrade in the presence of glutathione, which is designed for passive targeting to solid tumours. The conjugates exhibited well-defined structures with narrow molecular weight distributions of approx. 1.3 and pH-controlled drug release.
650    _2
$a akrylamidy $x chemie $7 D000178
650    _2
$a protinádorová antibiotika $x chemie $x farmakologie $7 D000903
650    _2
$a monoklonální protilátky $7 D000911
650    _2
$a doxorubicin $x chemie $x farmakologie $7 D004317
650    _2
$a nosiče léků $x chemie $7 D004337
650    _2
$a lékové transportní systémy $x metody $7 D016503
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a kinetika $7 D007700
650    _2
$a molekulární struktura $7 D015394
650    _2
$a polymerizace $7 D058105
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Etrych, Tomáš $7 xx0068504
700    1_
$a Kříž, Jaroslav, $d 1939- $7 xx0003977
700    1_
$a Šubr, Vladimír, $d 1957- $7 xx0088449
700    1_
$a Ulbrich, Karel, $d 1947- $7 jo2004259877
773    0_
$w MED00001639 $t European journal of pharmaceutical sciences official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 41, č. 3-4 (2010), s. 473-482
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20696244 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160318074831 $b ABA008
999    __
$a ok $b bmc $g 948906 $s 784210
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 41 $c 3-4 $d 473-482 $e 20100807 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
LZP    __
$b NLK113 $a Pubmed-20120816/11/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace